Less than a year after coming out of stealth mode with a $65 million first-round last year, artificial intelligence specialist Insitro has already signed its first biopharma partner. The South San ...

That includes Recursion – which made $436 million from its IPO – while Insitro and Insilico Medicine have made $400 million and $255 million, respectively, from their third rounds.

A MOTHER of two tries to keep her eyes open as she struggles to respond to questions asked by her partner, she has been beaten and is bleeding profusely from her head. Her name is Lina Numbalihi.